Form 4 Filing for Daly James M

On May 27, 2026, Daly James M, a director at CYTOKINETICS INC (CYTK), acquired 2,851 shares of Common Stock and was granted 4,301 Non-Qualified Stock Options. The stock acquisition was a direct ownership transaction with a transaction price of $0.00, resulting in 3,239 shares owned post-transaction. The stock options, also directly owned, have an exercise price of $77.15 and an expiration date of May 26, 2036. The options were acquired on May 27, 2026, with 4,301 shares underlying the options, and post-transaction, 4,301 shares are owned. This filing indicates a change in the insider's holdings.